BioCorRx Inc.
BICX
$0.41
$0.000.00%
OTC PK
| 12/31/2025 | 09/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -123.79% | 256.45% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -123.79% | 256.45% | |||
| Cost of Revenue | -193.92% | -- | |||
| Gross Profit | -32.74% | 55.11% | |||
| SG&A Expenses | -52.91% | -6.37% | |||
| Depreciation & Amortization | -273.33% | 0.00% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -85.16% | 62.09% | |||
| Operating Income | 72.54% | -37.61% | |||
| Income Before Tax | 41.72% | 41.30% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 41.72% | 41.30% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | 192.28% | -870.95% | |||
| Net Income | 128.81% | -55.50% | |||
| EBIT | 72.54% | -37.61% | |||
| EBITDA | 72.08% | -39.62% | |||
| EPS Basic | 122.54% | -45.66% | |||
| Normalized Basic EPS | 135.32% | -121.70% | |||
| EPS Diluted | 122.54% | -45.66% | |||
| Normalized Diluted EPS | 135.32% | -121.70% | |||
| Average Basic Shares Outstanding | 27.95% | 6.77% | |||
| Average Diluted Shares Outstanding | 27.95% | 6.77% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||